RETRACTED ARTICLE: Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease

5-Lipoxygenase (5LO) is upregulated in Alzheimer’s disease (AD) and in vivo modulates the amyloidotic phenotype of amyloid precursor protein transgenic mice. However, no data are available on the effects that 5LO has on synaptic function, integrity and cognition. To address this issue, we used a gen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular psychiatry 2014-04, Vol.19 (4), p.511-518
Hauptverfasser: Giannopoulos, P F, Chu, J, Joshi, Y B, Sperow, M, Li, J-G, Kirby, L G, Praticò, D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 518
container_issue 4
container_start_page 511
container_title Molecular psychiatry
container_volume 19
creator Giannopoulos, P F
Chu, J
Joshi, Y B
Sperow, M
Li, J-G
Kirby, L G
Praticò, D
description 5-Lipoxygenase (5LO) is upregulated in Alzheimer’s disease (AD) and in vivo modulates the amyloidotic phenotype of amyloid precursor protein transgenic mice. However, no data are available on the effects that 5LO has on synaptic function, integrity and cognition. To address this issue, we used a genetic and a pharmacological approach by generating 3 × Tg mice deficient for 5LO and administering 3 × Tg mice with a 5LO inhibitor. Compared with controls, we found that even before the development of overt neuropathology, both animals manifested significant memory improvement, rescue of their synaptic dysfunction and amelioration of synaptic integrity. In addition, later in life, these mice had a significant reduction of Aβ and tau pathology. Our findings support a novel functional role for 5LO in regulating synaptic plasticity and memory. They establish this protein as a pleiotropic contributor to the development of the full spectrum of the AD phenotype, making it a valid therapeutic target for the treatment of AD.
doi_str_mv 10.1038/mp.2013.23
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2645773167</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2645773167</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1763-700876127d1d2df6d00b849a07145423f47f4cd1903d62afc36eb2ebf3bb8c7b3</originalsourceid><addsrcrecordid>eNptkNtKw0AQhoMoeLzxCRa8EJTUPSWbeldqPUBBKPU6JLuz7WqyG3dTMb6Jb-uWCt54NQPzzf_P_ElyTvCIYFbctN2IYsJGlO0lR4SLPM0yUezHnmXjlJOCHybHIbxivB1mR8n3YrZcTKbL2R2aLJZP0_nsFj2ABfRmnXxzmx45jbK0MZ37HFZgqwDIQ5AbCCgMtup6I5Eagt5Y2RtnUWUVMm3n3UckWmidH5CxqF8D6r3pGkh7X9kQpeJi6xQ0W4dJ87UG04K_DEiZANHmNDnQVRPg7LeeJC_3s-X0MZ0_PzxNJ_NUEpGzVGBciJxQoYiiSucK47rg4woLwjNOmeZCc6nIGDOV00pLlkNNodasrgspanaSXOx0483v8a2-fHUbb6NlSXOeCcFILiJ1taOkdyF40GXnTVv5oSS43EZftl25jb6kLMLXOzhEyK7A_0n-Q_8AaT6GGw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2645773167</pqid></control><display><type>article</type><title>RETRACTED ARTICLE: Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease</title><source>SpringerLink Journals - AutoHoldings</source><creator>Giannopoulos, P F ; Chu, J ; Joshi, Y B ; Sperow, M ; Li, J-G ; Kirby, L G ; Praticò, D</creator><creatorcontrib>Giannopoulos, P F ; Chu, J ; Joshi, Y B ; Sperow, M ; Li, J-G ; Kirby, L G ; Praticò, D</creatorcontrib><description>5-Lipoxygenase (5LO) is upregulated in Alzheimer’s disease (AD) and in vivo modulates the amyloidotic phenotype of amyloid precursor protein transgenic mice. However, no data are available on the effects that 5LO has on synaptic function, integrity and cognition. To address this issue, we used a genetic and a pharmacological approach by generating 3 × Tg mice deficient for 5LO and administering 3 × Tg mice with a 5LO inhibitor. Compared with controls, we found that even before the development of overt neuropathology, both animals manifested significant memory improvement, rescue of their synaptic dysfunction and amelioration of synaptic integrity. In addition, later in life, these mice had a significant reduction of Aβ and tau pathology. Our findings support a novel functional role for 5LO in regulating synaptic plasticity and memory. They establish this protein as a pleiotropic contributor to the development of the full spectrum of the AD phenotype, making it a valid therapeutic target for the treatment of AD.</description><identifier>ISSN: 1359-4184</identifier><identifier>EISSN: 1476-5578</identifier><identifier>DOI: 10.1038/mp.2013.23</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/378/2591 ; 692/420/2489/144 ; 692/699/375/365/1283 ; 692/700/565 ; Behavioral Sciences ; Biological Psychology ; Medicine &amp; Public Health ; Neurosciences ; original-article ; Pharmacotherapy ; Psychiatry</subject><ispartof>Molecular psychiatry, 2014-04, Vol.19 (4), p.511-518</ispartof><rights>Macmillan Publishers Limited 2014</rights><rights>Macmillan Publishers Limited 2014.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1763-700876127d1d2df6d00b849a07145423f47f4cd1903d62afc36eb2ebf3bb8c7b3</citedby><cites>FETCH-LOGICAL-c1763-700876127d1d2df6d00b849a07145423f47f4cd1903d62afc36eb2ebf3bb8c7b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1038/mp.2013.23$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1038/mp.2013.23$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids></links><search><creatorcontrib>Giannopoulos, P F</creatorcontrib><creatorcontrib>Chu, J</creatorcontrib><creatorcontrib>Joshi, Y B</creatorcontrib><creatorcontrib>Sperow, M</creatorcontrib><creatorcontrib>Li, J-G</creatorcontrib><creatorcontrib>Kirby, L G</creatorcontrib><creatorcontrib>Praticò, D</creatorcontrib><title>RETRACTED ARTICLE: Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease</title><title>Molecular psychiatry</title><addtitle>Mol Psychiatry</addtitle><description>5-Lipoxygenase (5LO) is upregulated in Alzheimer’s disease (AD) and in vivo modulates the amyloidotic phenotype of amyloid precursor protein transgenic mice. However, no data are available on the effects that 5LO has on synaptic function, integrity and cognition. To address this issue, we used a genetic and a pharmacological approach by generating 3 × Tg mice deficient for 5LO and administering 3 × Tg mice with a 5LO inhibitor. Compared with controls, we found that even before the development of overt neuropathology, both animals manifested significant memory improvement, rescue of their synaptic dysfunction and amelioration of synaptic integrity. In addition, later in life, these mice had a significant reduction of Aβ and tau pathology. Our findings support a novel functional role for 5LO in regulating synaptic plasticity and memory. They establish this protein as a pleiotropic contributor to the development of the full spectrum of the AD phenotype, making it a valid therapeutic target for the treatment of AD.</description><subject>631/378/2591</subject><subject>692/420/2489/144</subject><subject>692/699/375/365/1283</subject><subject>692/700/565</subject><subject>Behavioral Sciences</subject><subject>Biological Psychology</subject><subject>Medicine &amp; Public Health</subject><subject>Neurosciences</subject><subject>original-article</subject><subject>Pharmacotherapy</subject><subject>Psychiatry</subject><issn>1359-4184</issn><issn>1476-5578</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNptkNtKw0AQhoMoeLzxCRa8EJTUPSWbeldqPUBBKPU6JLuz7WqyG3dTMb6Jb-uWCt54NQPzzf_P_ElyTvCIYFbctN2IYsJGlO0lR4SLPM0yUezHnmXjlJOCHybHIbxivB1mR8n3YrZcTKbL2R2aLJZP0_nsFj2ABfRmnXxzmx45jbK0MZ37HFZgqwDIQ5AbCCgMtup6I5Eagt5Y2RtnUWUVMm3n3UckWmidH5CxqF8D6r3pGkh7X9kQpeJi6xQ0W4dJ87UG04K_DEiZANHmNDnQVRPg7LeeJC_3s-X0MZ0_PzxNJ_NUEpGzVGBciJxQoYiiSucK47rg4woLwjNOmeZCc6nIGDOV00pLlkNNodasrgspanaSXOx0483v8a2-fHUbb6NlSXOeCcFILiJ1taOkdyF40GXnTVv5oSS43EZftl25jb6kLMLXOzhEyK7A_0n-Q_8AaT6GGw</recordid><startdate>20140401</startdate><enddate>20140401</enddate><creator>Giannopoulos, P F</creator><creator>Chu, J</creator><creator>Joshi, Y B</creator><creator>Sperow, M</creator><creator>Li, J-G</creator><creator>Kirby, L G</creator><creator>Praticò, D</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope></search><sort><creationdate>20140401</creationdate><title>RETRACTED ARTICLE: Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease</title><author>Giannopoulos, P F ; Chu, J ; Joshi, Y B ; Sperow, M ; Li, J-G ; Kirby, L G ; Praticò, D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1763-700876127d1d2df6d00b849a07145423f47f4cd1903d62afc36eb2ebf3bb8c7b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>631/378/2591</topic><topic>692/420/2489/144</topic><topic>692/699/375/365/1283</topic><topic>692/700/565</topic><topic>Behavioral Sciences</topic><topic>Biological Psychology</topic><topic>Medicine &amp; Public Health</topic><topic>Neurosciences</topic><topic>original-article</topic><topic>Pharmacotherapy</topic><topic>Psychiatry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Giannopoulos, P F</creatorcontrib><creatorcontrib>Chu, J</creatorcontrib><creatorcontrib>Joshi, Y B</creatorcontrib><creatorcontrib>Sperow, M</creatorcontrib><creatorcontrib>Li, J-G</creatorcontrib><creatorcontrib>Kirby, L G</creatorcontrib><creatorcontrib>Praticò, D</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Psychology</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><jtitle>Molecular psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Giannopoulos, P F</au><au>Chu, J</au><au>Joshi, Y B</au><au>Sperow, M</au><au>Li, J-G</au><au>Kirby, L G</au><au>Praticò, D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RETRACTED ARTICLE: Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease</atitle><jtitle>Molecular psychiatry</jtitle><stitle>Mol Psychiatry</stitle><date>2014-04-01</date><risdate>2014</risdate><volume>19</volume><issue>4</issue><spage>511</spage><epage>518</epage><pages>511-518</pages><issn>1359-4184</issn><eissn>1476-5578</eissn><abstract>5-Lipoxygenase (5LO) is upregulated in Alzheimer’s disease (AD) and in vivo modulates the amyloidotic phenotype of amyloid precursor protein transgenic mice. However, no data are available on the effects that 5LO has on synaptic function, integrity and cognition. To address this issue, we used a genetic and a pharmacological approach by generating 3 × Tg mice deficient for 5LO and administering 3 × Tg mice with a 5LO inhibitor. Compared with controls, we found that even before the development of overt neuropathology, both animals manifested significant memory improvement, rescue of their synaptic dysfunction and amelioration of synaptic integrity. In addition, later in life, these mice had a significant reduction of Aβ and tau pathology. Our findings support a novel functional role for 5LO in regulating synaptic plasticity and memory. They establish this protein as a pleiotropic contributor to the development of the full spectrum of the AD phenotype, making it a valid therapeutic target for the treatment of AD.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><doi>10.1038/mp.2013.23</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1359-4184
ispartof Molecular psychiatry, 2014-04, Vol.19 (4), p.511-518
issn 1359-4184
1476-5578
language eng
recordid cdi_proquest_journals_2645773167
source SpringerLink Journals - AutoHoldings
subjects 631/378/2591
692/420/2489/144
692/699/375/365/1283
692/700/565
Behavioral Sciences
Biological Psychology
Medicine & Public Health
Neurosciences
original-article
Pharmacotherapy
Psychiatry
title RETRACTED ARTICLE: Gene knockout of 5-lipoxygenase rescues synaptic dysfunction and improves memory in the triple-transgenic model of Alzheimer's disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T20%3A21%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RETRACTED%20ARTICLE:%20Gene%20knockout%20of%205-lipoxygenase%20rescues%20synaptic%20dysfunction%20and%20improves%20memory%20in%20the%20triple-transgenic%20model%20of%20Alzheimer's%20disease&rft.jtitle=Molecular%20psychiatry&rft.au=Giannopoulos,%20P%20F&rft.date=2014-04-01&rft.volume=19&rft.issue=4&rft.spage=511&rft.epage=518&rft.pages=511-518&rft.issn=1359-4184&rft.eissn=1476-5578&rft_id=info:doi/10.1038/mp.2013.23&rft_dat=%3Cproquest_cross%3E2645773167%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2645773167&rft_id=info:pmid/&rfr_iscdi=true